Zika Tools For Healthcare Providers
The Centers for Disease Control released tools for healthcare providers to diagnose Zika infection. These include testing algorithms and head circumference measurement guidance. Read More>> On August 8, ASTHO published an update to Top Questions on Zika: Simple Answers.
The document provides messages that can help officials answer frequently asked questions related to Zika prevention and response activities. In the latest version, ASTHO updated several sections including questions related to sexual transmission, federal response plans, and screening guidance. To find more information about the virus, visit ASTHO's Zika virus web page. ASTHO welcomes feedback on the document, as well as suggestions for additional candidate questions to be included in future versions. Please send to infocenter@astho.org. Serologic and PCR testing for Zika virus is now available at several commercial laboratories. Please follow CDC guidance for determining patients who have been potentially exposed to Zika. Patients who are Zika PCR negative may be testing positive for Zika virus IgM antibodies. Commercial laboratory IgM tests may not differentiate between Zika and other Flavivirus infections (Dengue, West Nile, Yellow Fever, etc.). Therefore, commercial Zika IgM results should be confirmed at the MDHHS Bureau of Laboratories.
*UPDATED*
via MDHHS For additional information on Zika, please visit: Updated KEY MESSAGES – ZIKA VIRUS DISEASE or www.cdc.gov/zika. Teresa Miller, Chemical Threat Response Training Coordinator, Michigan Department of Health and Human Services, Bureau of Laboratories
The Bureau of Laboratories, Michigan’s Public Health Laboratory began testing human clinical samples for Zika virus on May 9, 2016. Michigan is not a geographical hot zone for Zika virus. Our public health laboratory has allied with notable public health officials to perform clinical sample analysis for suspected human cases. Analysis of these clinical samples will aid epidemiologists and other scientific entities in finding definitive answers to concerns about contraction and spread of this viremic disease. Although the Bureau of Laboratories is not a research facility, characteristics of identified viral illness will aid in the quest for answers to our scientific questions about this virus. Read More>> |
Archives
January 2017
Archives
January 2017
Categories
All
|